Synthesis and antidepressant activity of some 1,3,5-triphenyl-2-pyrazolines and 3-(2"-hydroxy naphthalen-1"-yl)-1,5-diphenyl-2-pyrazolines

被引:348
作者
Prasad, YR [1 ]
Rao, AL [1 ]
Prasoona, L [1 ]
Murali, K [1 ]
Kumar, PR [1 ]
机构
[1] Andhra Univ, Univ Coll Pharmaceut Sci, Waltair 530003, Andhra Pradesh, India
关键词
antidepressant activity; 1,3,5-triphenyl pyrazolines; 3-(2 ''-naphthalen-1 ''-yl)-1,5-diphenyl-2-pyrazolines; forced-swimming test;
D O I
10.1016/j.bmcl.2005.08.040
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Five new 1,3,5-triphenyl-2-pyrazolines were synthesised by reacting 1,3-diphenyl-2-propene-1-one with phenyl hydrazine hydrochloride and another five new 3-(2"-hydroxy naphthalen-1"-yl)-1,5-diphenyl-2-pyrazolines were synthesised by reacting 1-(2'-hydroxynaphthyl)-3- henyl-2-propene-1-one with phenyl hydrazine hydrochloride. The structures of the compounds were proved by means of their IR, H-1 NMR spectroscopic data, and microanalyses. The antidepressant activity of these compounds was evaluated by the 'Porsolt behavioural despairtest' on Swiss-Webster mice. 1-Phenyl-3-(2"-hydroxyphenyl)-5-(4'-dimethylaminophenyl)-2-pyrazoline, 5-(4'-dimethylaminophenyl)-1, 3-diphenyl-2-pyrazo line, 1-phenyl-3-(2"-hydroxynaphthalen-1"-yl)-5-(3',4',5'-trimethoxyphenyl)-2-pyrazoline, 1-phenyl-3-(4"-methylphenyl)-5-(4-dimethylaminophenyl)-2-pyrazoline and 1-phenyl-3-(4"-bromophenyl)-5-(4'dimethyl amino phenyl)-2-pyrazo line reduced immobility times 25.63-59.25% at 100 mg/kg dose level. In addition, it was found that the compounds possessing electron-releasing groups such as dimethyl amino, methoxy and hydroxyl substituents, on both the aromatic rings at positions 3 and 5 of pyrazolines, considerably enhanced the antidepressant activity when compared to the pyrazolines having no substituents on the phenyl rings. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5030 / 5034
页数:5
相关论文
共 20 条
[1]  
BATULIN YM, 1968, FARMAKOL TOKSIKOL, V3, P533
[2]  
BILGIN AA, 1992, ARZNEIMITTEL-FORSCH, V42-2, P1271
[3]  
BILGIN AA, 1993, ARZNEIMITTEL-FORSCH, V43-2, P1041
[4]  
BILGIN AA, 1994, PHARMAZIE, V49, P67
[5]  
Dawey W., 1958, J CHEM SOC, P1320
[6]  
Erhan P., 2001, J MED CHEM, V36, P539
[7]   Comparison of behavioral effects of moclobemide and deprenyl during forced swimming [J].
Ferigolo, M ;
Barros, HMT ;
Marquardt, AR ;
Tannhauser, M .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1998, 60 (02) :431-437
[8]   MOCLOBEMIDE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN DEPRESSIVE-ILLNESS [J].
FITTON, A ;
FAULDS, D ;
GOA, KL .
DRUGS, 1992, 43 (04) :561-596
[9]  
Kohler E. P., 1941, ORG SYNTH, V1, P78
[10]  
MEHRA HS, 1968, J INDIAN CHEM SOC, V45, P178